Treatment with synthetic β-lactoglobulin peptides can prevent clinical symptoms in a mouse model for cow's milk allergy

Laura A.P.M. Meulenbroek(Utrecht University), L.M.J. Knippels, Johan Garssen(Utrecht University), B.C.A.M. van Esch, Linette E. M. Willemsen(Utrecht University), C. A. F. M. Bruijnzeel‐Koomen(Utrecht University), G.A. Hofman(Utrecht University), Els van Hoffen(University Medical Center Utrecht), Constance F. den Hartog Jager(University Medical Center Utrecht), Alma J. Nauta(Leiden University Medical Center)
PharmaNutrition
July 1, 2014
10.1016/j.phanu.2013.11.029
Cited by 0

Related Papers

Immunomodulatory properties of mesenchymal stromal cells
|Blood|2007|1.8k
Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E <sub>1</sub> and E <sub>2</sub> production by intestinal myofibroblasts
|Gut|2003|524
Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice
|Gut|2018|489
Altered gut microbiota and activity in a murine model of autism spectrum disorders
|Brain Behavior and Immunity|2013|436
Exploring Braak’s Hypothesis of Parkinson’s Disease
|Frontiers in Neurology|2017|388